Type: (null)
Journal: Clinical Breast Cancer
Year: 2002
Pages: 3, S69-S74
Neoadjuvant Docetaxel in Breast Cancer: 3-Year Survival Results from the Aberdeen Trial
Distribution of the number of citations over years.